Atrin Pharmaceuticals LLC — Form D/A
Atrin Pharmaceuticals LLC of DOYLESTOWN, PA, a company, filed a Form D amendment with the SEC on 2016-04-08. The offering totals $2.0M, of which $1.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-04-08
- Form: D/A
- Accession: 0001670487-16-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $1.5M
- Remaining: $500K
- Minimum investment: $25K
- Investors: 9
- Date of first sale: 2016-03-25
- Security types: equity, debt
- Revenue range: No Revenues
- SEC file number: 021-260462
Issuer
- Name: Atrin Pharmaceuticals LLC
- CIK: 0001670487
- Entity type: Limited Liability Company
- Jurisdiction: PENNSYLVANIA
- Address: 3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
- Phone: 215-589-6356
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Oren Gilad | Director | Doylestown, PA |
| Bernard C Rudnick | Director | Lancaster, PA |
| Oren Gilad | Executive Officer | Doylestown, PA |
| Bernard C Rudnick | Executive Officer | Lancaster, PA |
| Oren Gilad | Promoter | Doylestown, PA |
Other filings by this issuer (1)
More